88 results were returned
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").
So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.
Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...
In their response to the urgency of the COVID-19 crisis, contracting authorities within Europe have experienced many challenges.
Today the Court of Justice of the European Union (CJEU) handed down its decision in the Royalty Pharma case concerning the interpretation of Art. 3 a of Regulation EC 469/2009 on Supplementary Protection Certificates ...
The European Commission just published guidelines on the restrictions of the free movement principles in the context of the current COVID-19 crisis. Based on overriding public security and public health grounds, many ...
The UK’s National Cyber Security Centre (NCSC) along with the American Department of Homeland Security’s CISA have issued a specific warning to pharmaceutical companies, medical research organisations and universities.